As per the terms of this collaboration, Kollmann is expected to use Advaxis proprietary Listeria vaccine vectors for the development of novel infectious disease applications, and employ a
Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The company has operations in London, UK and Cambridge, MA. Antisoma,
The randomised, double-blind, placebo-controlled, multi-center Phase II clinical trial is expected to begin enrolling patients before the end of 2010 and is part of a collaboration between Athersys
SDIX has posted a net loss of $29,000 for the third quarter 2010, or $0 loss per diluted share, compared to net loss of $291,000 or $0.01 loss
The clinical research program will be led by Jeffrey Stout, MusclePharm’s scientific advisor, who will study the effects of MusclePharm’s products on high-intensity interval training, on aerobic and
The VersiDoser delivery platform is said to be a liquid delivery platform that comprises novel unit dose blister packaging, proprietary intranasal and ophthalmic delivery devices and aseptic manufacturing
The in-vivo maximisation sensitisation test method is designed to evaluate the allergenic potential or sensitising capacity of DispersinB wound spray. According to the company, the biocompatibility results confirm
Kendle has posted a net income of $1.55m for the third quarter 2010, or $0.1 per diluted share, compared to net income of $8.83m, or $0.59 per diluted
BDI’s portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or hyper immune globulins and other specialty injectables. BDI IT VP Tim
The patented, gene expression test uses a simple, noninvasive method of blood sample collection and can show the low probability of acute cellular rejection in stable heart transplant
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.